Alzheimer's disease-linked mutation of presenilin 2 (N141I-PS2) drastically lowers APPalpha secretion: control by the proteasome.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  1998-11-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/BBRC.1998.9619PMID 9813158
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• α‐Secretase‐Derived Product of β‐Amyloid Precursor Protein Is Decreased by Presenilin 1 Mutations Linked to Familial Alzheimer's Disease

  1997cited by this paper
• Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives.

  1997cited by this paper
• Presenilins: genes for life and death.

  1997cited by this paper
• Endoproteolytic Cleavage and Proteasomal Degradation of Presenilin 2 in Transfected Cells*

  1997cited by this paper
• The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue.

  1997cited by this paper
• Constitutive and Protein Kinase C‐Regulated Secretory Cleavage of Alzheimer's β‐Amyloid Precursor Protein: Different Control of Early and Late Events by the Proteasome

  1997cited by this paper
• Alpha-secretase-derived product of beta-amyloid precursor protein is decreased by presenilin 1 mutations linked to familial Alzheimer's disease.

  1997cited by this paper
• Amyloid, the presenilins and Alzheimer's disease.

  1997cited by this paper
• Enhanced Production and Oligomerization of the 42-residue Amyloid β-Protein by Chinese Hamster Ovary Cells Stably Expressing Mutant Presenilins*

  1997cited by this paper
• Characterization of New Polyclonal Antibodies Specific for 40 and 42 Amino Acid-Long Amyloid β Peptides: Their Use to Examine the Cell Biology of Presenilins and the Immunohistochemistry of Sporadic Alzheimer’s Disease and Cerebral Amyloid Angiopathy Cases

  1997cited by this paper
• The presenilins and Alzheimer's disease.

  1997cited by this paper
• Amyloid β-Protein and the Genetics of Alzheimer's Disease*

  1996cited by this paper
• Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo.

  1996cited by this paper
• Presenile because of presenilin: the presenilin genes and early onset Alzheimer's disease

  1996cited by this paper
• Processing of the β‐Amyloid Precursor Protein and Its Regulation in Alzheimer's Disease

  1995cited by this paper
• Processing of the beta-amyloid precursor protein and its regulation in Alzheimer's disease.

  1995cited by this paper
• Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.

  1992cited by this paper
• Production of the Alzheimer amyloid beta protein by normal proteolytic processing.

  1992cited by this paper
• Molecular genetics of Alzheimer disease amyloid.

  1991cited by this paper
• Rapid and efficient site-specific mutagenesis without phenotypic selection.

  1985cited by this paper

• Exercise Reverses Amyloid β-Peptide–Mediated Cognitive Deficits in Alzheimer’s Disease Mice Expressing Mutant Presenilin-2

  2021cites this paper
• Doença de Alzheimer de início precoce (DAIP): características neuropatológicas e variantes genéticas associadas.

  2021cites this paper
• Presenilin 1 and Presenilin 2 Target γ-Secretase Complexes to Distinct Cellular Compartments*

  2016cites this paper
• Pharmacogenomics in Drug Discovery and Development

  2014cites this paper
• The Functions of the Amyloid Precursor Protein Gene and Its Derivative Peptides: III Pharmacological Studies *

  2011cites this paper
• The functions of the amyloid precursor protein gene.

  2011cites this paper
• Upregulation of BACE1 and β-Amyloid Protein Mediated by Chronic Cerebral Hypoperfusion Contributes to Cognitive Impairment and Pathogenesis of Alzheimer’s Disease

  2009cites this paper
• Influência genética sobre a doença de Alzheimer de início tardio Genetic influence on late onset Alzeimer's disease

  2009cites this paper
• Pharmacogenomics in Alzheimer's disease.

  2008cites this paper
• Presenilin dependence of phospholipase C and protein kinase C signaling

  2007cites this paper
• Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.

  2007cites this paper
• Protein ubiquitination, degradation and the proteasome in neuro-degenerative disorders: no clear evidence for a significant pathogenetic role of proteasome failure in Alzheimer disease and related disorders.

  2006cites this paper
• Caspase-3-derived C-terminal Product of Synphilin-1 Displays Antiapoptotic Function via Modulation of the p53-dependent Cell Death Pathway*

  2006cites this paper
• Mutations in APP have independent effects on Aβ and CTFγ generation

  2004cites this paper
• Mutations in APP have independent effects on Abeta and CTFgamma generation.

  2004cites this paper
• Genetic and molecular aspects of Alzheimer's disease shed light on new mechanisms of transcriptional regulation

  2004cites this paper
• JLK isocoumarin inhibitors: Selective γ‐secretase inhibitors that do not interfere with notch pathway in vitro or in vivo

  2003cites this paper
• The C-terminal Fragment of Presenilin 2 Triggers p53-mediated Staurosporine-induced Apoptosis, a Function Independent of the Presenilinase-derived N-terminal Counterpart*

  2003cites this paper
• Alzheimer's Presenilin 1 Mutations Impair Kinesin-Based Axonal Transport

  2003cites this paper
• Fast axonal transport misregulation and Alzheimer’s Disease

  2002cites this paper
• Wild-type and mutated presenilins 2 trigger p53-dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons

  2002cites this paper
• Métabolisme du peptide

  2002cites this paper
• Métabolisme du précurseur du peptide amyloïde et présénilines

  2002cites this paper
• Molecular and cell biological aspects of Alzheimer disease

  2001cites this paper
• The ubiquitin‐proteasome pathway and proteasome inhibitors

  2001cites this paper
• KUOPION YLIOPISTO UNIVERSITY OF KUOPIO

  2001cites this paper
• Proteinase families and their inhibitors.

  2001cites this paper
• A unifying hypothesis of Alzheimer's disease. III. Risk factors

  2000cites this paper
• Role of the proteasome in Alzheimer's disease.

  2000cites this paper
• Phosphorylation of MARCKS in Alzheimer disease brains

  2000cites this paper
• Brain Expression of Presenilins in Sporadic and Early-onset, Familial Alzheimer’s Disease

  2000cites this paper
• Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomics.

  2000cites this paper
• Presenilin 2 expression in neuronal cells: induction during differentiation of embryonic carcinoma cells.

  2000cites this paper
• α-Synuclein and the Parkinson's disease-related mutant Ala53Thr-α-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells

  2000cites this paper
• Overexpression of Rab11 or Constitutively Active Rab11 Does Not Affect sAPPα and Aβ Secretions by Wild-Type and Swedish Mutated βAPP-Expressing HEK293 Cells

  2000cites this paper
• Alpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells.

  2000cites this paper
• Overexpression of Rab11 or constitutively active Rab11 does not affect sAPPalpha and Abeta secretions by wild-type and Swedish mutated betaAPP-expressing HEK293 cells.

  2000cites this paper
• C-Terminal Maturation Fragments of Presenilin 1 and 2 Control Secretion of APPα and Aβ by Human Cells and Are Degraded by Proteasome

  1999cites this paper
• S 17092-1, a highly potent, specific and cell permeant inhibitor of human proline endopeptidase.

  1999cites this paper
• [The presenilin mystery. The research winner-by-a knockout?].

  1999cites this paper
• C-terminal maturation fragments of presenilin 1 and 2 control secretion of APP alpha and A beta by human cells and are degraded by proteasome.

  1999cites this paper
• Presenilins

  1999cites this paper
• N-terminus truncated beta-amyloid peptides and C-terminus truncated secreted forms of amyloid precursor protein: distinct roles in the pathogenesis of Alzheimer's disease.

  1999cites this paper
• Presenilins: Multifunctional Proteins Involved in Alzheimer's Disease Pathology

  1999cites this paper
• Le mystère préséniline. La recherche vainqueur par KO

  1999cites this paper
• Genetic testing for Alzheimer's disease: how close is reality?

  1999cites this paper
• Induction of wild‐type p53, Bax, and acidic endonuclease during somatostatin‐signaled apoptosis in MCF‐7 human breast cancer cells

  1998cites this paper